KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Progyny (PGNY) EBITDA Margin (2018 - 2025)

Historic EBITDA Margin for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to 6.87%.

  • Progyny's EBITDA Margin rose 25200.0% to 6.87% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.77%, marking a year-over-year increase of 10200.0%. This contributed to the annual value of 5.78% for FY2024, which is 700.0% up from last year.
  • According to the latest figures from Q3 2025, Progyny's EBITDA Margin is 6.87%, which was up 25200.0% from 7.32% recorded in Q2 2025.
  • In the past 5 years, Progyny's EBITDA Margin ranged from a high of 9.67% in Q1 2021 and a low of 0.15% during Q4 2021
  • For the 5-year period, Progyny's EBITDA Margin averaged around 5.53%, with its median value being 5.81% (2023).
  • In the last 5 years, Progyny's EBITDA Margin soared by 107200bps in 2021 and then plummeted by -97000bps in 2022.
  • Over the past 5 years, Progyny's EBITDA Margin (Quarter) stood at 0.15% in 2021, then soared by 1147bps to 1.54% in 2022, then skyrocketed by 231bps to 5.11% in 2023, then rose by 3bps to 5.29% in 2024, then increased by 30bps to 6.87% in 2025.
  • Its EBITDA Margin was 6.87% in Q3 2025, compared to 7.32% in Q2 2025 and 7.46% in Q1 2025.